hasINN
P23160
predicate
Indicates that a pharmaceutical product or substance is associated with a specific International Nonproprietary Name (INN) assigned by the World Health Organization.
All labels observed (1)
| Label | Occurrences |
|---|---|
| hasINN canonical | 30 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasINN
Generated description
Indicates that a pharmaceutical product or substance is associated with a specific International Nonproprietary Name (INN) assigned by the World Health Organization.
Sample triples (30)
| Subject | Object |
|---|---|
| Leqembi |
lecanemab
ⓘ
linked to:
Leqembi
|
| Imbruvica | ibrutinib ⓘ |
| Avastin |
bevacizumab
ⓘ
linked to:
Avastin
|
| Rituxan |
rituximab
ⓘ
linked to:
Rituxan
|
| Donepezil |
donepezil
ⓘ
linked to:
Donepezil
|
| Alimta |
pemetrexed
ⓘ
linked to:
Alimta
|
| Emgality |
galcanezumab
ⓘ
linked to:
Emgality
|
| Ruxience |
rituximab
ⓘ
linked to:
Rituxan
|
| Keytruda |
pembrolizumab
ⓘ
linked to:
Keytruda
|
| maftivimab | maftivimab ⓘ |
| Inmazeb | atoltivimab ⓘ |
| Inmazeb | maftivimab ⓘ |
| Inmazeb | odesivimab ⓘ |
| Ibrance |
palbociclib
ⓘ
linked to:
Ibrance
|
| Imfinzi | durvalumab ⓘ |
| fingolimod | fingolimod ⓘ |
| larotrectinib | larotrectinib ⓘ |
| selpercatinib | selpercatinib ⓘ |
| inotersen | inotersen ⓘ |
| Humira | adalimumab ⓘ |
| Hemlibra | emicizumab ⓘ |
| Vabysmo | faricimab ⓘ |
| rosuvastatin | rosuvastatin ⓘ |
| sulfasalazine | sulfasalazine ⓘ |
| Andexxa | andexanet alfa ⓘ |
| Ondexxya | andexanet alfa ⓘ |
| isatuximab | isatuximab ⓘ |
| Zabdeno | Ad26.ZEBOV ⓘ |
| acalabrutinib | acalabrutinib ⓘ |
| neratinib | neratinib ⓘ |